Company intelligence / Profile preview

Hunan Hansen Pharmaceutical

Yiyang, Hunan, China

Ownership: Private
Employees: ~1536
Development stage: Commercial

Overview

Hunan Hansen Pharmaceutical is a leading pharmaceutical company in China focused on the research, development, manufacture and sales of traditional Chinese medicine preparations and chemical medicines. Its main products are approved and commercialized in China for indications such as digestive disorders, memory impairment, anemia/iron deficiency and hyperthyroidism. The company has a broad portfolio with over 129 species and 186 drug production specifications approved.

Therapeutic areas: NephrologyEndocrinologyHematologyOtherGastroenterologyCardiovascularNeurology
Modalities: Small moleculeHerbal medicineDiagnostic radiopharmaceuticals
Industry: Biotech

Drug pipeline

2 assets

Lidan Zhitong Jiaonang

Unknown

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on Hunan Hansen Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hunan Hansen Pharmaceutical.

Explore the full profile